Acquisition context Pulsar Vascular was acquired by Codman Neuro in December 2016, indicating potential alignment with larger neurovascular portfolios and access to broader distribution and resources for sales outreach.

Neurovascular focus Specializes in minimally invasive devices for endovascular treatment of neurovascular disorders, presenting a clear target for sales efforts to neurointerventional centers, hospitals with vascular programs, and specialty distributors.

Clinical stage As a clinical stage medical device manufacturer with a demonstrated pipeline, there is opportunity to position emerging products to early adopters and key opinion leaders within neurovascular teams.

Financial signal Reported revenue in the low seven figures suggests room for expansion through additional product lines, broader hospital adoption, and cross-sell opportunities within Codman Neuro's ecosystem.

Market alignment Compact company with potential for integration into larger medtech platforms; prospect to leverage partnerships, distribution channels, and capital for scaling sales of neurovascular devices.